ADEMPAS

Brand name authorized in: Austria Australia Brazil Canada Cyprus Spain Finland France Hong Kong Ireland Lithuania Netherlands New Zealand Poland Singapore United Kingdom United States

Active ingredients

The drug ADEMPAS contains one active pharmaceutical ingredient (API):

1 Riociguat
UNII RU3FE2Y4XI - RIOCIGUAT

Riociguat is a stimulator of soluble guanylate cyclase (sGC), an enzyme in the cardiopulmonary system and the receptor for nitric oxide (NO). Riociguat restores the NO-sGC-cGMP pathway and leads to increased generation of cGMP.

Read about Riociguat

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
C02KX05
Riociguat
C Cardiovascular system → C02 Antihypertensives → C02K Other antihypertensives → C02KX Antihypertensives for pulmonary arterial hypertension
Discover more medicines within C02KX05

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
ADEMPAS Film-coated tablet
Summary of Product Characteristics (SPC)

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
AU
Pharmaceutical Benefits Scheme
Identifier(s): 10974N, 10975P, 10976Q, 10977R, 10984D, 10985E, 10989J, 10990K, 10995Q, 11001B, 11002C, 11008J, 11009K, 11010L, 11012N, 11013P, 11017W, 11018X, 11019Y, 11020B, 11024F, 11028K, 11030M, 11031N, 11035T, 11038Y, 11039B, 11040C, 11045H, 11046J, 11047K, 11048L, 11052Q, 11053R, 11054T, 11057Y, 11058B, 11059C, 11060D, 11061E
BR
Câmara de Regulação do Mercado de Medicamentos
Identifier(s): 538916010025301, 538916010025501, 538916010025701, 538916010025801, 538916010025901, 538916010026001, 538916010026101, 538916010026201
CA
Health Products and Food Branch
Identifier(s): 02412764, 02412772, 02412799, 02412802, 02412810
ES
Centro de información online de medicamentos de la AEMPS
Identifier(s): 113907004, 113907007, 113907010, 113907013
FI
Lääkealan turvallisuus- ja kehittämiskeskus
Identifier(s): 069347, 112191, 135090, 164827, 165799, 415368, 485304, 541846, 561780
FR
Base de données publique des médicaments
Identifier(s): 60025054, 60203795, 61875550, 64832942, 66086562
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 243980, 243985, 243994, 243998, 243999, 244007, 244009
HK
Department of Health Drug Office
Identifier(s): 63505, 63509, 63510, 63511, 63512
IE
Health Products Regulatory Authority
Identifier(s): 88599, 88690, 88692, 88694, 88695, 89068, 89069
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1073042, 1073043, 1073044, 1073045, 1073046, 1073047, 1073048, 1073049, 1073050, 1073051, 1073052, 1073053, 1073054, 1073055, 1073056, 1074977, 1074978, 1074979, 1074980, 1074981
NL
Z-Index G-Standaard, PRK
Identifier(s): 124656, 124664, 124672, 124680, 124699
NZ
Medicines and Medical Devices Safety Authority
Identifier(s): 16951, 16952, 16953, 16954, 16955
PL
Rejestru Produktów Leczniczych
Identifier(s): 100322670, 100322686, 100322692, 100322700, 100322717
SG
Health Sciences Authority
Identifier(s): 14678P, 14679P, 14680P, 14681P, 14682P
US
FDA, National Drug Code
Identifier(s): 50419-250, 50419-251, 50419-252, 50419-253, 50419-254